Friday 6 November 2026 Export MIRM’s income statement to Excel — free account

Mirum Pharmaceuticals, Inc.

Mirum Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $521.3 million, up 54.7% from fiscal 2024.

Revenue: +39.6%
EPS: −1,136.8%
Free cash flow: −114.2%
Total debt: +136.4%

Quarter to September 2026, against a year earlier

93.82 0.28 +0.30%

Follow MIRM

Alert me

Market cap: $6.1B
P/E: 0.0×
Fwd P/E: −5.6×
Dividend yield: —
F-score: 6/9
Altman Z: 4.42
Beneish M: −2.46
Dividend safety: n/a

Overview

Mirum Pharmaceuticals, Inc. (MIRM) P/B ratio

Alert me on P/B ratio

Mirum Pharmaceuticals, Inc. has no meaningful P/B ratio: its trailing twelve-month book value is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 30.0× (June 2026) — the current reading is the lowest in ten years.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/MIRM/pb-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Mirum Pharmaceuticals, Inc. P/B ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/MIRM/metrics/pb-ratio">Mirum Pharmaceuticals, Inc. (MIRM) P/B ratio — stockrow.com</a></p>

Period	P/B ratio	Change
FY2025	12.6×	44.68%
FY2024	8.7×	76.45%
FY2023	4.9×	7.45%
FY2022	4.6×	14.17%
FY2021	4.0×	—

Period	P/B ratio	Change
Sep 2026	0.0×	—
Jun 2026	0.0×	—
Mar 2026	22.4×	77.93%
Dec 2025	12.6×	(0.88%)
18 more quarters	Free account

Against its own ten years

Low 0.0× High 30.0×

Ten-year median 5.4×

Current reading's percentile 8

Company	P/B ratio
MIRM Mirum Pharmaceuticals, Inc.	n/m
PTCT PTC Therapeutics, Inc. compare	n/m
ORKA Oruka Therapeutics, Inc. compare	5.5×
CGON CG Oncology, Inc. compare	5.6×
LGND Ligand Pharmaceuticals Incorporated compare	6.2×
BLTE Belite Bio, Inc. Sponsored ADR compare	7.5×
IMVT Immunovant, Inc. compare	8.0×
IONS Ionis Pharmaceuticals, Inc. compare	14.6×
KOD Kodiak Sciences Inc. compare	94.0×
Biotechnology industry median	2.0×
Healthcare sector median	2.3×
Market median	1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

Mirum Pharmaceuticals, Inc. (MIRM) P/B ratio

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on MIRM

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on MIRM

Stockrow Weekly